Mild Cognitive Impairment Due to AD
1 clinical trials · Condition
◉ Watch Mild Cognitive Impairment Due to AD
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD (NCT04498650) | Vivoryon Therapeutics N.V. | 2020-07-06 |
Track Mild Cognitive Impairment Due to AD automatically
Every clearance here is in the API, with alerts when new ones post.